Multimedia

W. Clay Jackson, MD, DipTh, explains the difference between major depressive disorder and major depressive disorder with mixed features.

Krista Gilbert, PhD, LMFT, joins the BHE Podcast to discuss transitioning from her early career aspirations of being, in her words, “a therapist for life” to her current role as chief executive officer of Constellation Behavioral Health.

Sanjay J. Mathew, MD, speaks about best practices for administering esketamine during his Psych Congress 2019 presentation "Top 5 Issues Clinicians Should Know about Ketamine Therapy."

In this video, forensic psychiatrist Phillip J. Resnick, MD discusses common traits in school shooters, misconceptions people have about school shooters, and how mental health clinicians can help prevent school shootings.

On the debut episode of the BHE Podcast, Jaime Vinck, CEO of Sierra Tucson Group, discusses a busy six months that has included the opening of a new behavioral healthcare building, the launch of a new individual treatment program with wraparound services, and more.

Michael Thase, MD, discusses when clinicians should consider using thyroid hormone as an antidepressant augmentation strategy and possible risks of the approach.

Ben Cort, CEO of Foundry Treatment Center Steamboat Springs in Colorado, discusses the importance of avoiding microaggressions when working with cannabis-dependent patients, as well as the differences between the marijuana of 20 years and the products used today, and more effective questions around cannabis use to ask during intake.

D. Tyler Coyle, MD, MS, of the University School of Medicine – Addiction Research and Treatment Services, dispels misconceptions around the safety of medications such as buprenorphine and methadone in patients who are breastfeeding or pregnant, and emphasizes the importance of becoming familiar with relevant local laws, regulations and community resources when treating patients, which can vary by…

Anthony L. Rostain, MD, MA, discusses steps to take when treating attention-deficit/hyperactivity disorder (ADHD) in patients with hypertension or cardiovascular disease.

Anthony L. Rostain, MD, MA, discusses factors to consider when combining stimulants and nonstimulants in the treatment of attention-deficit/hyperactivity disorder (ADHD).